Old Web
English
Sign In
Acemap
>
authorDetail
>
David Parma
David Parma
Anschutz Medical Campus
Oligonucleotide
Aptamer
Molecular biology
Biochemistry
Systematic evolution of ligands by exponential enrichment
4
Papers
390
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
2001
Journal of Biological Chemistry
Brian J. Hicke
Chris Marion
Ying-Fon Chang
Ty A. Gould
Cynthia K. Lynott
David Parma
Paul Schmidt
Steve Warren
Show All
Source
Cite
Save
Citations (276)
Anti-L-Selectin Aptamers: Binding Characteristics, Pharmacokinetic Parameters, and Activity Against an Intravascular Target In Vivo
2000
Antisense & Nucleic Acid Drug Development
Susan R Watson
Ying-Fon Chang
Dan OConnell
Laurie Weigand
Steven Ringquist
David Parma
Show All
Source
Cite
Save
Citations (68)
Site-Directed Selection of Oligonucleotide Antagonists by Competitive Elution
1999
Antisense & Nucleic Acid Drug Development
Philippe Bridonneau
Ying-Fon Chang
Ada Velati-Bellini Buvoli
Dan OConnell
David Parma
Show All
Source
Cite
Save
Citations (16)
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2)
1998
Journal of Medicinal Chemistry
Philippe Bridonneau
Ying-Fon Chang
Dan OConnell
Stanley C. Gill
David W. Snyder
Lea M. Johnson
Theodore Goodson
David K. Herron
David Parma
Show All
Source
Cite
Save
Citations (30)
1